Skip to main content

Centene Value Stock - Dividend - Research Selection

Centene

ISIN: US15135B1017 , WKN: 766458

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children\'s health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here’s how

2026-05-04
When Centene Corporation reported its first-quarter results in late April, the numbers told two stories that seemed impossible to reconcile. The St. Louis-based insurer had hemorrhaged customers, watching its Affordable Care Act marketplace membership collapse from 5.6 million to 3.6 million in just one year — a drop of roughly 2 million people. Yet the ... This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here’s how

Centene (CNC) Is Up 22.6% After Strong Q1 Beat And Raised 2026 Outlook - What's Changed

2026-05-04
In late April 2026, Centene Corporation reported first-quarter revenue of US$49.94 billion and net income of US$1.54 billion, with diluted earnings per share from continuing operations of US$3.11, all higher than the same period a year earlier. At the same time, Centene raised its full-year 2026 guidance, projecting total revenue of US$187.50 billion to US$191.50 billion and GAAP diluted EPS above US$2.37, signaling management’s increased confidence in its operating performance and...

What Moved Markets This Week

2026-05-02

S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner

2026-05-01
AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.

Centene: Further Upside Will Require Better Execution

2026-05-01
Centene rebounded in Q1-2026 with significant improvement in its HBR, dropping to 87.3% from 94.3% in Q4-2025. Read more on CNC stock here.

UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?

2026-05-01
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.

Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $56

2026-05-01
Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $44 to $56.

Parsley Health Becomes the First Functional Medicine Provider to Accept Insurance Nationwide

2026-04-30
NEW YORK, April 30, 2026--Parsley Health, the first company that brought functional medicine to a national audience, is now the first to bring it into the mainstream insurance system. Starting today, its physician-led, root cause care is available nationwide through in-network insurance, expanding access to 150 million Americans through the coverage they already have.

This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday

2026-04-30
Top analysts downgraded APPN and XOMA stocks. Visit analyst ratings page to see other views. Should you buy APPN? Check out analysts' opinions

This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

2026-04-30
Top analysts change outlook on top names, including upgrades, downgrades, and initiations. Check out analyst ratings page for complete view.